REMERON is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Organon Usa Inc.. The primary component is Mirtazapine.
Product ID | 0052-0105_1594f744-89b7-488d-bf1b-516340e924f9 |
NDC | 0052-0105 |
Product Type | Human Prescription Drug |
Proprietary Name | REMERON |
Generic Name | Mirtazapine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1996-06-14 |
Marketing Category | NDA / NDA |
Application Number | NDA020415 |
Labeler Name | Organon USA Inc. |
Substance Name | MIRTAZAPINE |
Active Ingredient Strength | 15 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1996-06-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020415 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1996-06-14 |
Ingredient | Strength |
---|---|
MIRTAZAPINE | 15 mg/1 |
SPL SET ID: | 010f9162-9f7f-4b6d-a6e4-4f832f26f38e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0052-0105 | REMERON | MIRTAZAPINE |
0052-0107 | REMERON | MIRTAZAPINE |
0052-0109 | REMERON | MIRTAZAPINE |
0052-4364 | REMERON | MIRTAZAPINE |
0052-4365 | REMERON | MIRTAZAPINE |
70518-0903 | REMERON | REMERON |
70518-2176 | REMERON | REMERON |
0093-7206 | Mirtazapine | Mirtazapine |
0093-7207 | Mirtazapine | Mirtazapine |
0093-7208 | Mirtazapine | Mirtazapine |
0115-1653 | Mirtazapine | Mirtazapine |
0115-1654 | Mirtazapine | Mirtazapine |
0115-1656 | Mirtazapine | Mirtazapine |
0185-0020 | mirtazapine | mirtazapine |
0052-0106 | REMERONSOLTAB | MIRTAZAPINE |
0052-0108 | REMERONSOLTAB | MIRTAZAPINE |
0052-0110 | REMERONSOLTAB | MIRTAZAPINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REMERON 74552154 2061796 Live/Registered |
MERCK SHARP & DOHME B.V. 1994-07-21 |